[go: up one dir, main page]

DK0537313T3 - Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet - Google Patents

Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet

Info

Publication number
DK0537313T3
DK0537313T3 DK92909059.5T DK92909059T DK0537313T3 DK 0537313 T3 DK0537313 T3 DK 0537313T3 DK 92909059 T DK92909059 T DK 92909059T DK 0537313 T3 DK0537313 T3 DK 0537313T3
Authority
DK
Denmark
Prior art keywords
dioxo
dihydro
dihydroxy
arylalkyl esters
therapeutic activity
Prior art date
Application number
DK92909059.5T
Other languages
Danish (da)
English (en)
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Application granted granted Critical
Publication of DK0537313T3 publication Critical patent/DK0537313T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/95—Esters of quinone carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
DK92909059.5T 1991-05-03 1992-04-21 Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet DK0537313T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911215A IT1247884B (it) 1991-05-03 1991-05-03 Esteri arilalchilici dell'acido 4,5 diidrossi-9,10-diidro-9,10-diosso 2-antracencarbossilico ad azione terapeutica

Publications (1)

Publication Number Publication Date
DK0537313T3 true DK0537313T3 (da) 1996-06-03

Family

ID=11359835

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909059.5T DK0537313T3 (da) 1991-05-03 1992-04-21 Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet

Country Status (21)

Country Link
US (1) US5330981A (sv)
EP (1) EP0537313B1 (sv)
JP (1) JPH0692348B2 (sv)
KR (1) KR100226082B1 (sv)
AT (1) ATE133157T1 (sv)
AU (1) AU648894B2 (sv)
BR (1) BR9205255A (sv)
CZ (1) CZ280027B6 (sv)
DE (1) DE69207698T2 (sv)
DK (1) DK0537313T3 (sv)
ES (1) ES2082468T3 (sv)
FI (1) FI104166B (sv)
GR (1) GR3019417T3 (sv)
HU (1) HUT63605A (sv)
IT (1) IT1247884B (sv)
MX (1) MX9202015A (sv)
NO (1) NO179245C (sv)
PT (1) PT100439B (sv)
RU (1) RU2087462C1 (sv)
SK (1) SK280738B6 (sv)
WO (1) WO1992019584A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
EP1642885B1 (en) 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
CN101475484B (zh) * 2009-01-05 2012-07-18 东南大学 骨靶向抗炎药物合成方法及其应用
CN103709052B (zh) * 2014-01-12 2016-01-27 何黎琴 一种大黄酸胺基醇酯类化合物、其制备方法及医药用途
CN104945269A (zh) * 2015-06-23 2015-09-30 常州善美药物研究开发中心有限公司 一种大黄酸羧酸酯类衍生物及其应用
CN109053798B (zh) * 2018-07-23 2020-11-17 遵义医科大学 一种大黄酸酯衍生物及其制备方法与应用
CN115521320B (zh) * 2021-06-25 2023-09-05 沈阳兴齐眼药股份有限公司 一种制备普拉洛芬的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis

Also Published As

Publication number Publication date
DE69207698T2 (de) 1996-07-18
GR3019417T3 (en) 1996-06-30
FI104166B1 (sv) 1999-11-30
NO925048D0 (no) 1992-12-30
IT1247884B (it) 1995-01-05
ES2082468T3 (es) 1996-03-16
FI925944L (fi) 1992-12-30
MX9202015A (es) 1992-11-01
RU2087462C1 (ru) 1997-08-20
SK386492A3 (en) 1995-04-12
FI925944A0 (fi) 1992-12-30
FI104166B (sv) 1999-11-30
NO925048L (no) 1992-12-30
ATE133157T1 (de) 1996-02-15
CZ280027B6 (cs) 1995-09-13
KR100226082B1 (en) 1999-10-15
ITMI911215A0 (it) 1991-05-03
CZ386492A3 (en) 1993-06-16
PT100439B (pt) 1999-10-29
HU9204171D0 (en) 1993-04-28
WO1992019584A1 (en) 1992-11-12
PT100439A (pt) 1993-08-31
US5330981A (en) 1994-07-19
DE69207698D1 (de) 1996-02-29
EP0537313A1 (en) 1993-04-21
SK280738B6 (sk) 2000-07-11
ITMI911215A1 (it) 1992-11-03
NO179245B (no) 1996-05-28
NO179245C (no) 1996-09-04
HUT63605A (en) 1993-09-28
BR9205255A (pt) 1993-08-31
AU648894B2 (en) 1994-05-05
JPH0692348B2 (ja) 1994-11-16
JPH05507733A (ja) 1993-11-04
AU1670092A (en) 1992-12-21
EP0537313B1 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
DE69600084D1 (de) Verwendung von hydroxylierte Carbonsäure zur Behandlung von Nägeln
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
DE3772247D1 (de) Diacetylrheinsaeure-kaliumsalze und seine verwendung zur behandlung von arthritis.
DK0537313T3 (da) Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet
FR2491334B1 (sv)
SE9300758D0 (sv) Process for the production of clavulanic acid
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DK0413329T3 (da) 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
DE58904726D1 (de) Verwendung von n-phenyl-substituierten oxazindionen als herbizide sowie n-phenyl-substituierte oxazindione und mehrere verfahren zu deren herstellung.
FI962549A0 (sv) Metallisk implant och förfarande för behandling av en metallisk implant
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
ES2019981B3 (es) Amido acido benzofurancarbono basico sustituido, metodo de fabricacion y productos terapeuticos contenidos
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE3878529D1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
ES2122236T3 (es) Sal de lisina de la 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida.
AT358573B (de) Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxy- propyl-2))-amin und dessen saeureadditions- salzen und optisch aktiven isomeren
IT8821163A0 (it) Telomeri dell'1,2 dicloro 1,2 difluoroetilene e processo per laloro preparazione.
FR2686441B1 (fr) Procede de gestion et d'ordonnancement du travail personnel d'un individu.
IT8019033A0 (it) Metodo per il trattamento disuperfici siero-essudanti dell'epidermide, ferite, piaghe esimili, e mezzi per la sua attuazione.
ATE101054T1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.